Axon Enterprise 10-Q 2026-09-30
AXON · CIK 1069183 · Form 10-Q · Period ended September 30, 2026 · Filed November 6, 2026
Revenue rose 27.8% to $909 million. Operating margin was 4.6%, against -0.3% a year earlier. Net income was $57.0 million.
8 sections, 209K characters. Original on sec.gov · ·
| Measure | Quarter ended Sep 30, 2026 | Quarter ended Sep 30, 2025 | Change |
|---|---|---|---|
| Revenue | $909M | $711M | +27.8% |
| Operating income | $42.1M | -$2.13M | n/a |
| Net income | $57.0M | -$2.19M | n/a |
| Diluted EPS | $0.68 | -$0.03 | n/a |
| Cash and equivalents | $1.46B | n/a | n/a |
| Operating margin* | 4.6% | -0.3% | +4.9 pts |
From the XBRL facts tagged to this filing; both columns are as reported in this filing. * Computed by filings.tools: free cash flow is operating cash flow less capital spending; operating margin is operating income over revenue.
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2026
or
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from __________to __________
Commission File Number: 001-16391
| Axon Enterprise, Inc. | ||||||||
| (Exact name of registrant as specified in its charter) |
| Delaware | 86-0741227 | ||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
| 17800 North 85th Street | |||||
| Scottsdale, Arizona | 85255 | ||||
| (Address of principal executive offices) | (Zip Code) |
(1-800) 978-2737
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Common Stock, $0.00001 Par Value | AXON | The NASDAQ Stock Market LLC |
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | x | Accelerated filer | o | |||||||||||
| Non-accelerated filer | o | Smaller reporting company | o | |||||||||||
| Emerging growth company | o |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
The number of shares of the registrant’s common stock outstanding as of October 30, 2026 was 81,432,712.
AXON ENTERPRISE, INC.
INDEX TO QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2026
Special Note Regarding Forward-Looking Statements
Statements contained in this Quarterly Report on Form 10-Q that are not historical are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including statements regarding our expectations, beliefs, intentions and strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. Such statements give our current expectations or forecasts of future events; they do not relate strictly to historical or current facts. Words such as “may,” “will,” “should,” “could,” “would,” “predict,” “potential,” “continue,” “expect,” “anticipate,” “future,” “intend,” “plan,” “believe,” “estimate,” and similar expressions, as well as statements in future tense, identify forward-looking statements. However, not all forward-looking statements contain these identifying words.
We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. Achievement of future results is subject to risks, uncertainties and potentially inaccurate assumptions. Many events beyond our control may determine whether results we anticipate will be achieved. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected. The material factors, which could cause our actual results to differ from our forward-looking statements, are set forth in our description of risk factors included in Part I, Item 1A, “Risk Factors” in our 2025 Annual Report on Form 10-K for the year ended December 31, 2025 and Part II, Item 1A, “Risk Factors” in this Quarterly Report on Form 10-Q, which should be read in conjunction with the forward-looking statements in this Quarterly Report on Form 10-Q. These factors are intended as cautionary statements for investors within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties.
Except as required by law, we undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our Form 8-K, 10-Q and 10-K reports to the Securities and Exchange Commission (“SEC”). Our filings with the SEC may be accessed at the SEC’s website at www.sec.gov.
ii
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
AXON ENTERPRISE, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
| September 30, 2026 | December 31, 2025 | ||||||||||
| (Unaudited) | |||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 1,458,817 | $ | 1,201,147 | |||||||
| Short-term investments | 181,587 | 505,417 | |||||||||
| Marketable securities | 14,751 | 27,213 | |||||||||
| Accounts and notes receivable, net of allowance of $4,451 and $4,198 as of September 30, 2026 and December 31, 2025, respectively | 838,294 | 777,486 | |||||||||
| Contract assets, net | 866,856 | 582,630 | |||||||||
| Inventory | 579,225 | 341,811 | |||||||||
| Prepaid expenses | 201,603 | 149,800 | |||||||||
| Other current assets | 141,084 | 127,548 | |||||||||
| Total current assets | 4,282,217 | 3,713,052 | |||||||||
| Property and equipment, net | 357,342 | 330,979 | |||||||||
| Deferred tax assets, net | 333,585 | 359,803 | |||||||||
| Intangible assets, net | 268,817 | 196,972 | |||||||||
| Goodwill | 1,885,348 | 1,370,189 | |||||||||
| Long-term notes receivable, net | 1,704 | 6,066 | |||||||||
| Long-term contract assets, net | 298,906 | 178,249 | |||||||||
| Strategic investments | 924,934 | 416,833 | |||||||||
| Other long-term assets | 479,924 | 428,170 | |||||||||
| Total assets | $ | 8,832,777 | $ | 7,000,313 | |||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 249,940 | $ | 139,086 | |||||||
| Accrued liabilities | 398,475 | 510,538 | |||||||||
| Current portion of deferred revenue | 742,247 | 714,708 | |||||||||
| Current portion of notes payable, net | — | 80,552 | |||||||||
| Customer deposits | 17,020 | 16,156 | |||||||||
| Other current liabilities | 19,220 | 9,107 | |||||||||
| Total current liabilities | 1,426,902 | 1,470,147 | |||||||||
| Deferred revenue, net of current portion | 435,326 | 359,902 | |||||||||
| Liability for unrecognized tax benefits | 26,517 | 24,376 | |||||||||
| Long-term deferred compensation | 34,573 | 23,675 | |||||||||
| Long-term lease liabilities | 100,861 | 98,942 | |||||||||
| Long-term notes payable, net | 2,868,037 | 1,730,170 | |||||||||
| Other long-term liabilities | 177,633 | 50,443 | |||||||||
| Total liabilities | 5,069,849 | 3,757,655 | |||||||||
| Commitments and contingencies (Note 11) | |||||||||||
| Stockholders’ equity: | |||||||||||
| Preferred stock, $0.00001 par value; 25,000,000 shares authorized; no shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | — | — | |||||||||
| Common stock, $0.00001 par value; 200,000,000 shares authorized, 101,686,312 shares issued and 81,411,739 shares outstanding as of September 30, 2026, and 200,000,000 shares authorized, 100,444,971 shares issued and 80,211,537 shares outstanding as of December 31, 2025 | 1 | 1 | |||||||||
| Additional paid-in capital | 2,764,868 | 2,475,035 | |||||||||
| Treasury stock at cost, 20,274,573 shares and 20,233,434 shares as of September 30, 2026 and December 31, 2025, respectively | (180,164) | (157,242) | |||||||||
| Retained earnings | 1,192,415 | 936,670 | |||||||||
| Accumulated other comprehensive loss | (14,192) | (11,806) | |||||||||
| Total stockholders’ equity | 3,762,928 | 3,242,658 | |||||||||
| Total liabilities and stockholders’ equity | $ | 8,832,777 | $ | 7,000,313 |
The accompanying notes are an integral part of these consolidated financial statements.
AXON ENTERPRISE, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME
(in thousands, except per share data)
(unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Net sales from products | $ | 471,524 | $ | 405,399 | $ | 1,430,898 | $ | 1,122,655 | |||||||||||||||
| Net sales from services | 437,030 | 305,242 | 1,189,390 | 860,157 | |||||||||||||||||||
| Net sales | 908,554 | 710,641 | 2,620,288 | 1,982,812 | |||||||||||||||||||
| Cost of product sales | 268,629 | 203,173 | 744,646 | 566,861 | |||||||||||||||||||
| Cost of service sales | 124,947 | 80,120 | 336,931 | 219,121 | |||||||||||||||||||
| Cost of sales | 393,576 | 283,293 | 1,081,577 | 785,982 | |||||||||||||||||||
| Gross margin | 514,978 | 427,348 | 1,538,711 | 1,196,830 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Selling, general and administrative | 280,496 | 252,803 | 830,571 | 718,524 | |||||||||||||||||||
| Research and development | 192,402 | 176,674 | 590,039 | 490,264 | |||||||||||||||||||
| Total operating expenses | 472,898 | 429,477 | 1,420,610 | 1,208,788 | |||||||||||||||||||
| Income (loss) from operations | 42,080 | (2,129) | 118,101 | (11,958) | |||||||||||||||||||
| Interest income | 5,657 | 23,941 | 23,083 | 57,798 | |||||||||||||||||||
| Interest expense | (28,337) | (28,912) | (85,081) | (65,419) | |||||||||||||||||||
| Other income, net | 59,520 | 22,803 | 255,722 | 104,790 | |||||||||||||||||||
| Income before provision for income taxes | 78,920 | 15,703 | 311,825 | 85,211 | |||||||||||||||||||
| Provision for (benefit from) income taxes | 21,914 | 17,889 | 56,080 | (36,700) | |||||||||||||||||||
| Net income (loss) | $ | 57,006 | $ | (2,186) | $ | 255,745 | $ | 121,911 | |||||||||||||||
| Net income (loss) per common and common equivalent shares: | |||||||||||||||||||||||
| Basic | $ | 0.70 | $ | (0.03) | $ | 3.17 | $ | 1.57 | |||||||||||||||
| Diluted | $ | 0.68 | $ | (0.03) | $ | 3.08 | $ | 1.48 | |||||||||||||||
| Weighted average number of common and common equivalent shares outstanding: | |||||||||||||||||||||||
| Basic | 81,044 | 78,416 | 80,592 | 77,774 | |||||||||||||||||||
| Diluted | 83,673 | 78,416 | 82,928 |
Showing the first 8K of 120K characters. Open the full section
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition as of September 30, 2026, and results of operations for the three and nine months ended September 30, 2026 and 2025, should be read in conjunction with the unaudited consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and related notes in our 2025 Annual Report on Form 10-K for the year ended December 31, 2025. The discussion includes references to non-GAAP financial measures, such as adjusted gross margin, which supplement our GAAP results by providing additional insight into our financial and operational performance. For definitions and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures, refer to “Non-GAAP Measures” within this Quarterly Report on Form 10-Q. This discussion also contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated in such forward-looking statements.
Overview
Axon is a technology company that provides integrated hardware and software solutions. Our products and services allow customers across the public and private sector to capture and use critical data to support fully-connected operational workflows. Our trusted network seamlessly integrates software and hardware with a range of connected devices, including TASER energy devices, cameras and sensors, drones and robotics, cloud-based evidence management, records management, real-time operations software, critical incident and emergency response systems, immersive training, and productivity tools – all enhanced by artificial intelligence.
Our revenues for the three months ended September 30, 2026 were $908.6 million, an increase of $197.9 million, or 27.8%, from the three months ended September 30, 2025. We had income from operations of $42.1 million, compared to loss from operations of $2.1 million for the same period in the prior year. Gross margin dollars increased $87.6 million and decreased as a percentage of revenue to 56.7% from 60.1% compared to the three months ended September 30, 2025. Adjusted gross margin decreased to 59.2% for the three months ended September 30, 2026 compared to 62.7% for the same period in the prior year. The decrease in gross margin and adjusted gross margin was primarily driven by an increased mix of counter-drone equipment, scaling of new product offerings and higher memory costs. Operating expenses increased by $43.4 million, primarily reflecting increased headcount and investments in AI and other initiatives to support business growth. Net income of $57.0 million included a $21.9 million tax provision, income from strategic investments, net, of $64.1 million, and an unrealized loss of $4.4 million related to our marketable securities. Net loss of $2.2 million for the three months ended September 30, 2025 included a $17.9 million tax provision, net realized and unrealized gains of $14.6 million related to our strategic investments, and a net realized and unrealized gain of $8.3 million related to our marketable securities.
Our revenues for the nine months ended September 30, 2026 were $2.6 billion, an increase of $637.5 million, or 32.2%, from the nine months ended September 30, 2025. We had income from operations of $118.1 million, compared to loss from operations of $12.0 million for the same period in the prior year. Gross margin dollars increased $341.9 million and decreased as a percentage of revenue to 58.7% from 60.4% compared to the nine months ended September 30, 2025. Adjusted gross margin decreased to 61.2% for the nine months ended September 30, 2026 compared to 63.2% for the same period in the prior year. The decrease in gross margin and adjusted gross margin was primarily due to a higher mix of professional services revenue, scaling of new product offerings and higher memory costs, partially offset by tariff refunds received during the nine months ended September 30, 2026. Operating expenses increased by $211.8 million, primarily reflecting increased headcount and investments in AI and other initiatives to support business growth. Net income of $255.7 million included net realized and unrealized gains of $266.4 million related to our strategic investments and a $56.1 million tax provision, partially offset by a net realized and unrealized loss of $8.8 million related to our marketable securities. Net income of $121.9 million for the nine months ended September 30, 2025 included net realized and unrealized gains of $180.6 million related to our strategic investments and a $36.7 million tax benefit, partially offset by a net realized and unrealized loss of $46.0 million related to our marketable securities and inducement expense of $28.7 million associated with the early repurchase of a portion of our 2027 Notes.
On February 20, 2026, the Supreme Court determined that tariffs imposed under the International Emergency Economic Powers Act (“IEEPA”) were unauthorized. During the three months ended June 30, 2026, we received $47.4 million in refunds. Of this amount, $18.1 million had been previously expensed in 2025 to cost of sales and the remaining is associated with amounts primarily classified as inventory and property and equipment, net, for which the majority would have been expensed in the current year. There were no material changes related to tariff refunds during the three months ended September 30, 2026.
Results of Operations
Three Months Ended September 30, 2026 Compared to the Three Months Ended September 30, 2025
The following table presents data from our consolidated statements of operations as well as the percentage relationship to total net sales (dollars in thousands):
| Three Months Ended September 30, | |||||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| Net sales from products | $ | 471,524 | 51.9 | % | $ | 405,399 | 57.0 | % | |||||||||||||||
| Net sales from services | 437,030 | 48.1 | 305,242 | 43.0 | |||||||||||||||||||
| Net sales | 908,554 | 100.0 | 710,641 | 100.0 | |||||||||||||||||||
| Cost of product sales | 268,629 | 29.6 | 203,173 | 28.6 | |||||||||||||||||||
| Cost of service sales | 124,947 | 13.7 | 80,120 | 11.3 | |||||||||||||||||||
| Cost of sales | 393,576 | 43.3 | 283,293 | 39.9 | |||||||||||||||||||
| Gross margin | 514,978 | 56.7 | 427,348 | 60.1 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Selling, general and administrative | 280,496 | 30.9 | 252,803 | 35.6 | |||||||||||||||||||
| Research and development | 192,402 | 21.2 | 176,674 | 24.8 | |||||||||||||||||||
| Total operating expenses | 472,898 | 52.1 | 429,477 | 60.4 | |||||||||||||||||||
| Income (loss) from operations | 42,080 | 4.6 | (2,129) | (0.3) | |||||||||||||||||||
| Interest income | 5,657 | 0.6 | 23,941 | 3.4 | |||||||||||||||||||
| Interest expense | (28,337) | (3.1) | (28,912) | (4.1) | |||||||||||||||||||
| Other income, net | 59,520 | 6.6 | 22,803 | 3.2 | |||||||||||||||||||
| Income before provision for income taxes | 78,920 | 8.7 | 15,703 | 2.2 | |||||||||||||||||||
| Provision for income taxes | 21,914 | 2.4 | 17,889 | 2.5 | |||||||||||||||||||
| Net income (loss) | $ | 57,006 | 6.3 | % | $ | (2,186) | (0.3) | % |
The following table presents our revenues disaggregated by geography (dollars in thousands):
| Three Months Ended September 30, | |||||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| United States | $ | 772,026 | 85 | % | $ | 593,939 | 84 | % | |||||||||||||||
| Other countries | 136,528 | 15 | 116,702 | 16 | |||||||||||||||||||
| Total | $ | 908,554 | 100 | % | $ | 710,641 | 100 | % |
International revenue increased compared to the prior year September 30, 2025 comparative period, primarily driven by increased sales in our EMEA region.
Net Sales
Net sales by product line were as follows (dollars in thousands):
| Three Months Ended September 30, | Dollar Change | Percent Change | |||||||||||||||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||||||||||||||
| Connected Devices segment: | |||||||||||||||||||||||||||||||||||
| TASER (1) | $ | 233,040 | 25.6 | % | $ | 237,950 | 33.5 | % | $ | (4,910) | (2.1) | % | |||||||||||||||||||||||
| Personal Sensors (2) | 113,532 | 12.5 | 106,677 | 15.0 | 6,855 | 6.4 | |||||||||||||||||||||||||||||
| Platform Solutions (3) | 124,952 | 13.8 | 60,772 | 8.5 | 64,180 | 105.6 | |||||||||||||||||||||||||||||
| Total Connected Devices segment | 471,524 | 51.9 | 405,399 | 57.0 | 66,125 | 16.3 | |||||||||||||||||||||||||||||
| Total Software and Services segment | 437,030 | 48.1 | 305,242 | 43.0 | 131,788 | 43.2 | |||||||||||||||||||||||||||||
| Total net sales | $ | 908,554 | 100.0 | % | $ | 710,641 | 100.0 | % | $ | 197,913 | 27.8 | % |
(1)'TASER' includes TASER devices, cartridges and related extended warranties.
(2)'Personal Sensors' primarily includes body cameras and accessories, signal sidearm, and related extended warranties.
(3)'Platform Solutions' primarily includes fleet in-car video, interview room, fixed cameras, drones and counter-drone equipment, virtual reality training hardware, and related extended warranties.
Net sales for the Connected Devices segment increased 16.3% for the three months ended September 30, 2026 compared to the three months ended September 30, 2025. The decrease of $4.9 million in TASER is primarily driven by legacy TASER volume, partially offset by higher TASER 10 cartridge volume. Personal Sensors increased $6.9 million primarily attributable to continued adoption of our newest body camera, AB4, and higher warranty revenue from more devices in the field. The $64.2 million increase in Platform Solutions is primarily driven by higher volume for counter-drone equipment, which may be subject to increased volatility driven by the timing of large customer contracts.
Net sales for the Software and Services segment increased 43.2% for the three months ended September 30, 2026 compared to the three months ended September 30, 2025. The increase in the aggregate number of users and growing adoption of our premium solutions by existing customers drove the majority of the increase of $131.8 million.
Gross Margin
As a percentage of net sales, gross margin for the Connected Devices segment decreased to 43.0% from 49.9% for the three months ended September 30, 2026 and 2025, respectively. Adjusted gross margin for the Connected Devices segment was 44.6% for the three months ended September 30, 2026, compared to 52.1% for the three months ended September 30, 2025. The decrease in gross margin and adjusted gross margin was primarily driven by an increased mix of counter-drone equipment and higher memory costs.
As a percentage of net sales, gross margin for the Software and Services segment decreased to 71.4% from 73.8% for the three months ended September 30, 2026 and 2025, respectively. Adjusted gross margin for the Software and Services segment decreased to 75.0% for the three months ended September 30, 2026, compared to 76.8% for the three months ended September 30, 2025. The decrease in gross margin and adjusted gross margin was primarily driven by the scaling of new product offerings and a higher mix of professional services revenue.
Selling, General and Administrative Expenses
SG&A expenses were as follows (dollars in thousands):
| Three Months Ended September 30, | Dollar Change | Percent Change | |||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| Total selling, general and administrative expenses | $ | 280,496 | $ | 252,803 | $ | 27,693 | 11.0 | % | |||||||||||||||
| As a percentage of net sales | 30.9% | 35.6% |
Salaries, benefits and bonus expense increased $7.3 million in comparison to the prior year September 30, 2025 comparable period, primarily attributable to an increase in headcount.
Sales and marketing expense increased $7.1 million in comparison to the prior year September 30, 2025 comparable period, primarily attributable to increased commissions.
Other SG&A expenses increased $13.3 million in comparison to the prior year September 30, 2025 comparable period, primarily driven by increased technology license expenses of $4.7 million as a result of the continued adoption of AI initiatives, as well as increased stock-based compensation expenses of $3.2 million which were partially attributable to an increase in headcount.
Research and Development Expenses
R&D expenses were as follows (dollars in thousands):
| Three Months Ended September 30, | Dollar Change | Percent Change | |||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| Total research and development expenses | $ | 192,402 | $ | 176,674 | $ | 15,728 | 8.9 | % | |||||||||||||||
| As a percentage of net sales | 21.2 | % | 24.8 | % |
Salaries, benefits and bonus expense increased $6.5 million in comparison to the prior year September 30, 2025 comparable period, which was primarily attributable to an increase in headcount.
Other R&D expenses increased $9.2 million in comparison to the prior year September 30, 2025 comparable period, primarily driven by increased stock-based compensation expenses of $6.8 million which were partially attributable to an increase in headcount.
Interest Income (Expense), Net
Interest income (expense), net, was as follows (in thousands):
| Three Months Ended September 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| Interest income (1) | $ | 5,657 | $ | 23,941 | |||||||
| Interest expense | (28,337) | (28,912) | |||||||||
| Total interest expense, net | $ | (22,680) | $ | (4,971) |
(1)Interest income decreased primarily due to lower average balances of short-term investments compared to the prior year September 30, 2025 comparable period.
Other Income, Net
Other income, net, was as follows (in thousands):
| Three Months Ended September 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| Income from strategic investments, net (1) | $ | 64,117 | $ | 14,618 | |||||||
| Realized and unrealized gain (loss) on marketable securities, net (2) | (4,375) | 8,275 | |||||||||
| Loss on foreign currency transactions, net | (317) | (160) | |||||||||
| Other, net | 95 | 70 | |||||||||
| Other income, net | $ | 59,520 | $ | 22,803 |
(1)Reflects the net realized and unrealized income (loss) associated with our strategic investments, during the three months ended September 30, 2026 and 2025, as discussed within Note 6.
(2)Reflects the net realized and unrealized gain (loss) on marketable securities, during the three months ended September 30, 2026 and 2025, as discussed within Note 3.
Provision for Income Taxes
The effective tax rate was 27.8% for the three months ended September 30, 2026, compared to 113.9% for the three months ended September 30, 2025. The decrease in effective tax rate for the quarter was primarily driven by higher pre-tax book income which reduced the relative impact of permanent and discrete tax items, along with a greater benefit from R&D tax credits, partially offset by a lower net tax benefit from stock-based compensation.
Provision for income taxes and effective tax rates were as follows (dollars in thousands):
| Three Months Ended September 30, | |||||||||||||||||
| 2026 | 2025 | Change | |||||||||||||||
| Income before provision for income taxes | $ | 78,920 | $ | 15,703 | $ | 63,217 | |||||||||||
| Provision for income taxes | $ | 21,914 | $ | 17,889 | $ | 4,025 | |||||||||||
| Effective tax rate | 27.8 | % | 113.9 | % |
Net Income
We recorded net income of $57.0 million for the three months ended September 30, 2026 compared to net loss of $2.2 million for the three months ended September 30, 2025. Net income (loss) per basic share was $0.70 for the three months ended September 30, 2026 compared to $(0.03) for the three months ended September 30, 2025. Net income (loss) per diluted share was $0.68 for the three months ended September 30, 2026 compared to $(0.03) for the three months ended September 30, 2025.
Nine Months Ended September 30, 2026 Compared to the Nine Months Ended September 30, 2025
The following table presents data from our consolidated statements of operations as well as the percentage relationship to total net sales (dollars in thousands):
| Nine Months Ended September 30, | |||||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| Net sales from products | $ | 1,430,898 | 54.6 | % | $ | 1,122,655 | 56.6 | % | |||||||||||||||
| Net sales from services | 1,189,390 | 45.4 | 860,157 | 43.4 | |||||||||||||||||||
| Net sales | 2,620,288 | 100.0 | 1,982,812 | 100.0 | |||||||||||||||||||
| Cost of product sales | 744,646 | 28.4 | 566,861 | 28.6 | |||||||||||||||||||
| Cost of service sales | 336,931 | 12.9 | 219,121 | 11.0 | |||||||||||||||||||
| Cost of sales | 1,081,577 | 41.3 | 785,982 | 39.6 | |||||||||||||||||||
| Gross margin | 1,538,711 | 58.7 | 1,196,830 | 60.4 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Selling, general and administrative | 830,571 | 31.7 | 718,524 | 36.2 | |||||||||||||||||||
| Research and development | 590,039 | 22.5 | 490,264 | 24.8 | |||||||||||||||||||
| Total operating expenses | 1,420,610 | 54.2 | 1,208,788 | 61.0 | |||||||||||||||||||
| Income (loss) from operations | 118,101 | 4.5 | (11,958) | (0.6) | |||||||||||||||||||
| Interest income | 23,083 | 0.9 | 57,798 | 2.9 | |||||||||||||||||||
| Interest expense | (85,081) | (3.2) | (65,419) | (3.3) | |||||||||||||||||||
| Other income, net | 255,722 | 9.7 | 104,790 | 5.3 | |||||||||||||||||||
| Income before provision for income taxes | 311,825 | 11.9 | 85,211 | 4.3 | |||||||||||||||||||
| Provision for (benefit from) income taxes | 56,080 | 2.1 | (36,700) | (1.8) | |||||||||||||||||||
| Net income | $ | 255,745 | 9.8 | % | $ | 121,911 | 6.1 | % |
The following table presents our revenues disaggregated by geography (dollars in thousands):
| Nine Months Ended September 30, | |||||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| United States | $ | 2,160,860 | 82 | % | $ | 1,660,695 | 84 | % | |||||||||||||||
| Other countries | 459,428 | 18 | 322,117 | 16 | |||||||||||||||||||
| Total | $ | 2,620,288 | 100 | % | $ | 1,982,812 | 100 | % |
International revenue increased compared to the prior year September 30, 2025 comparative period, primarily driven by increased sales in our EMEA region.
Net Sales
Net sales by product line were as follows (dollars in thousands):
| Nine Months Ended September 30, | Dollar Change | Percent Change | |||||||||||||||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||||||||||||||
| Connected Devices segment: | |||||||||||||||||||||||||||||||||||
| TASER (1) | $ | 727,214 | 27.8 | % | $ | 649,679 | 32.8 | % | $ | 77,535 | 11.9 | % | |||||||||||||||||||||||
| Personal Sensors (2) | 317,675 | 12.1 | 287,901 | 14.5 | 29,774 | 10.3 | |||||||||||||||||||||||||||||
| Platform Solutions (3) | 386,009 | 14.7 | 185,075 | 9.3 | 200,934 | 108.6 | |||||||||||||||||||||||||||||
| Total Connected Devices segment | 1,430,898 | 54.6 | 1,122,655 | 56.6 | 308,243 | 27.5 | |||||||||||||||||||||||||||||
| Total Software and Services segment | 1,189,390 | 45.4 | 860,157 | 43.4 | 329,233 | 38.3 | |||||||||||||||||||||||||||||
| Total net sales | $ | 2,620,288 | 100.0 | % | $ | 1,982,812 | 100.0 | % | $ | 637,476 | 32.2 | % |
(1)'TASER' includes TASER devices, cartridges and related extended warranties.
(2)'Personal Sensors' primarily includes body cameras and accessories, signal sidearm, and related extended warranties.
(3)'Platform Solutions' primarily includes fleet in-car video, interview room, fixed cameras, drones and counter-drone equipment, virtual reality training hardware, and related extended warranties.
Net sales for the Connected Devices segment increased 27.5% for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025. The increase of $77.5 million in TASER is primarily driven by higher TASER 10 device and cartridge volume. Personal Sensors increased $29.8 million primarily attributable to continued adoption of our newest body camera, AB4, and higher warranty revenue from more devices in the field. The $200.9 million increase in Platform Solutions is primarily driven by higher volume of counter-drone equipment, which may be subject to increased volatility driven by the timing of large customer contracts.
Net sales for the Software and Services segment increased 38.3% for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025. The increase in the aggregate number of users and growing adoption of our premium add-on features by existing customers drove the majority of the increase of $329.2 million.
Gross Margin
As a percentage of net sales, gross margin for the Connected Devices segment decreased to 48.0% from 49.5% for the nine months ended September 30, 2026 and 2025, respectively. Adjusted gross margin for the Connected Devices segment was 49.6% for the nine months ended September 30, 2026, compared to 52.0% for the nine months ended September 30, 2025. The decrease in gross margin and adjusted gross margin was primarily driven by an increased mix of counter-drone equipment and higher memory costs, partially offset by tariff refunds.
As a percentage of net sales, gross margin for the Software and Services segment decreased to 71.7% from 74.5% for the nine months ended September 30, 2026 and 2025, respectively. Adjusted gross margin for the Software and Services segment decreased to 75.3% for the nine months ended September 30, 2026, compared to 77.8% for the nine months ended September 30, 2025. The decrease in gross margin and adjusted gross margin was primarily driven by a higher mix of professional services revenue and scaling of new product offerings.
Selling, General and Administrative Expenses
SG&A expenses were as follows (dollars in thousands):
| Nine Months Ended September 30, | Dollar Change | Percent Change | |||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| Total selling, general and administrative expenses | $ | 830,571 | $ | 718,524 | $ | 112,047 | 15.6 | % | |||||||||||||||
| As a percentage of net sales | 31.7% | 36.2% |
Salaries, benefits and bonus expense increased $30.1 million in comparison to the prior year September 30, 2025 comparable period, primarily attributable to an increase in headcount.
Sales and marketing expense increased $26.2 million in comparison to the prior year September 30, 2025 comparable period, primarily attributable to increased commissions.
Other SG&A expenses increased $55.7 million in comparison to the prior year September 30, 2025 comparable period, primarily attributable to increased advisory expenses of $18.6 million, $11.2 million of increased technology license expenses as a result of the continued adoption of AI initiatives, and increased travel expenses of $10.0 million.
Research and Development Expenses
R&D expenses were as follows (dollars in thousands):
| Nine Months Ended September 30, | Dollar Change | Percent Change | |||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||
| Total research and development expenses | $ | 590,039 | $ | 490,264 | $ | 99,775 | 20.4 | % | |||||||||||||||
| As a percentage of net sales | 22.5 | % | 24.8 | % |
Salaries, benefits and bonus expense increased $47.9 million in comparison to the prior year September 30, 2025 comparable period, which was primarily attributable to an increase in headcount.
Stock-based compensation expense increased $15.4 million in comparison to the prior year September 30, 2025 comparable period, partially attributable to increased headcount.
Other R&D expenses increased $36.5 million in comparison to the prior year September 30, 2025 comparable period, primarily driven by $12.4 million of increased technology license expenses as a result of the continued adoption of AI initiatives and $10.0 million of increased engineering expenses.
Interest Income (Expense), Net
Interest income (expense), net, was as follows (in thousands):
| Nine Months Ended September 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| Interest income (1) | $ | 23,083 | $ | 57,798 | |||||||
| Interest expense | (85,081) | (65,419) | |||||||||
| Total interest expense, net | $ | (61,998) | $ | (7,621) |
(1)Interest income decreased primarily due to lower average balances of short-term investments compared to the prior year September 30, 2025 comparable period.
Other Income, Net
Other income, net, was as follows (in thousands):
| Nine Months Ended September 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| Income from strategic investments, net (1) | $ | 266,426 | $ | 180,642 | |||||||
| Realized and unrealized loss on marketable securities, net (2) | (8,811) | (45,994) | |||||||||
| Loss on foreign currency transactions, net | (1,906) | (1,376) | |||||||||
| Induced conversion of convertible debt | — | (28,666) | |||||||||
| Other, net | 13 | 184 | |||||||||
| Other income, net | $ | 255,722 | $ | 104,790 |
(1)Reflects the net realized and unrealized income associated with our strategic investments, during the nine months ended September 30, 2026 and 2025, as discussed within Note 6.
(2)Reflects the net realized and unrealized loss on marketable securities, during the nine months ended September 30, 2026 and 2025, as discussed within Note 3.
Provision for Income Taxes
The effective tax rate was 18.0% for the nine months ended September 30, 2026, compared to (43.1)% for the nine months ended September 30, 2025. The increase in effective tax rate for the nine months ended September 30, 2026 was primarily driven by higher pre-tax book income which reduced the relative impact of permanent and discrete items, a less favorable net tax benefit from stock-based compensation, and higher state income taxes, partially offset by more favorable R&D tax credits and the favorable impact of a gain on an investment transaction not recognized for tax purposes.
Provision for (benefit from) income taxes and effective tax rates were as follows (dollars in thousands):
| Nine Months Ended September 30, | |||||||||||||||||
| 2026 | 2025 | Change | |||||||||||||||
| Income before provision for income taxes | $ | 311,825 | $ | 85,211 | $ | 226,614 | |||||||||||
| Provision for (benefit from) income taxes | $ | 56,080 | $ | (36,700) | $ | 92,780 | |||||||||||
| Effective tax rate | 18.0 | % | (43.1) | % |
Net Income
We recorded net income of $255.7 million for the nine months ended September 30, 2026 compared to net income of $121.9 million for the nine months ended September 30, 2025. Net income per basic share was $3.17 for the nine months ended September 30, 2026 compared to $1.57 for the nine months ended September 30, 2025. Net income per diluted share was $3.08 for the nine months ended September 30, 2026 compared to $1.48 for the nine months ended September 30, 2025.
Non-GAAP Measures
We utilize certain non-GAAP financial measures such as EBITDA, adjusted EBITDA, and adjusted gross margin as defined below to enhance understanding of our financial results and related measures. We have adjusted for expenses that we believe are not indicative of our core operating results. Our management uses these non-GAAP financial measures in evaluating our operating performance. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance, and when planning and forecasting our future periods. A reconciliation of GAAP to the non-GAAP financial measures is presented below.
Beginning in the quarterly period ended March 31, 2026, we updated the calculation of Adjusted EBITDA to exclude all components of other income (loss), net – primarily resulting in incremental adjustments for foreign currency exchange gains and losses, net and fees incurred related to our Credit Agreement, as we do not consider these adjustments to be representative of our core operating results. For all comparable prior periods presented, our adjustment for other income (loss), net does not include the above incremental items, as the impact of this change on historical periods was determined to be de minimis. Accordingly, other income (loss), net for all comparable prior periods has not been recast and solely reflects adjustment for the impacts of net realized and unrealized gains on strategic investments and marketable securities, net realized gains on previously held minority interests acquired in business combinations and debt inducement expense.
Furthermore, beginning in the quarterly period ended June 30, 2026, we updated the calculation of Adjusted EBITDA and Adjusted Gross Margin to exclude additional jurisdiction-specific compensation-related taxes incurred as a direct result of Employee XSP vesting events. This update expands upon our existing adjustment, which was historically limited to payroll taxes related to Employee XSP vesting events. For all comparable prior periods presented, our adjustment does not include any incremental jurisdiction-specific compensation-related taxes, as the impact of this change on historical periods was determined to be de minimis. Accordingly, compensation taxes related to Employee XSP vesting for all comparable prior periods has not been recast and solely reflects adjustment for payroll taxes incurred.
-
EBITDA (most comparable GAAP measure: Net income) – Earnings before interest expense, investment interest income, income taxes, depreciation and amortization.
-
Adjusted EBITDA (most comparable GAAP measure: Net income) – Earnings before interest expense; investment interest income; income taxes; depreciation; amortization; all components of other income (loss), net, which is primarily comprised of fair value adjustments and income or losses related to strategic investments and marketable securities, debt inducement expense associated with the early repurchase of a portion of our 2027 Notes, foreign currency exchange gains and losses, net, and fees incurred related to our Credit Agreement; noncash stock-based compensation expense; transaction and integration costs related to strategic investments and acquisitions, including the change in fair value of contingent consideration arrangements and certain compensation costs directly related to employee integration activities; non-recurring severance costs, including employee cash payments, equity, and related benefits; costs (or subsequent recoveries of prior costs) related to certain legal or regulatory matters we consider outside of our core operating activities; mark-to-market adjustments on our non-qualified deferred compensation liabilities; compensation taxes related to Employee XSP vesting; losses incurred as a result of the disposal, abandonment, and impairment of property, equipment, and intangible assets, and inventory step-up amortization related to acquisitions.
-
Adjusted gross margin (most comparable GAAP measure: Gross margin) – Gross margin before noncash stock-based compensation expense; compensation taxes related to Employee XSP vesting; amortization of acquired intangible assets; non-recurring severance costs, including employee cash payments, equity, and related benefits; and inventory step-up amortization related to acquisitions.
Although these non-GAAP financial measures are not consistent with GAAP, management believes investors will benefit by referring to these non-GAAP financial measures when assessing our operating results, as well as when forecasting and analyzing future periods. However, management recognizes that:
-
these non-GAAP financial measures are limited in their usefulness and should be considered only as a supplement to our GAAP financial measures;
-
these non-GAAP financial measures should not be considered in isolation from, or as a substitute for, our GAAP financial measures;
-
these non-GAAP financial measures should not be considered to be superior to our GAAP financial measures; and
-
these non-GAAP financial measures were not prepared in accordance with GAAP and investors should not assume that the non-GAAP financial measures presented in this Quarterly Report on Form 10-Q were prepared under a comprehensive set of rules or principles.
EBITDA and adjusted EBITDA reconcile to net income as follows (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Net income (loss) | $ | 57,006 | $ | (2,186) | $ | 255,745 | $ | 121,911 | |||||||||||||||
| Depreciation and amortization | 32,357 | 21,310 | 93,318 | 59,829 | |||||||||||||||||||
| Interest expense | 28,337 | 28,912 | 85,081 | 65,419 | |||||||||||||||||||
| Investment interest income | (5,657) | (23,941) | (23,083) | (57,798) | |||||||||||||||||||
| Provision for (benefit from) income taxes | 21,914 | 17,889 | 56,080 | (36,700) | |||||||||||||||||||
| EBITDA | $ | 133,957 | $ | 41,984 | $ | 467,141 | $ | 152,661 | |||||||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||
| Other income, net | (59,520) | (22,893) | (255,722) | (105,981) | |||||||||||||||||||
| Stock-based compensation expense | 151,312 | 146,152 | 429,317 | 425,635 | |||||||||||||||||||
| Transaction and integration costs related to strategic investments and acquisitions (1) | 7,242 | 4,774 | 18,290 | 9,731 | |||||||||||||||||||
| Compensation taxes related to Employee XSP vesting | 185 | — | 9,717 | 9,782 | |||||||||||||||||||
| Litigation and regulatory costs | 2,380 | 5,490 | 5,600 | 8,313 | |||||||||||||||||||
| Severance costs (1) | — | — | 2,730 | — | |||||||||||||||||||
| Non-qualified deferred compensation liability adjustments | — | 1,073 | 2,137 | 2,634 | |||||||||||||||||||
| Loss on disposal, abandonment, and impairment of property, equipment and intangible assets, net | 104 | 430 | 104 | 430 | |||||||||||||||||||
| Inventory step-up amortization | — | — | — | 607 | |||||||||||||||||||
| Adjusted EBITDA | $ | 235,660 | $ | 177,010 | $ | 679,314 | $ | 503,812 |
(1)For the three and nine months ended September 30, 2026, non-recurring compensation costs were $5.5 million and $8.2 million, respectively. These costs consisted of stock-based compensation, cash payments and employee benefits, the majority of which derived from acquisition integration activities.
Adjusted gross margin reconciles to gross margin as follows (in thousands):
| Three Months Ended September 30, | |||||||||||||||||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||||||||||||||
| Connected Devices | Software and Services | Total | Connected Devices | Software and Services | Total | ||||||||||||||||||||||||||||||
| Gross margin | $ | 202,895 | $ | 312,083 | $ | 514,978 | $ | 202,226 | $ | 225,122 | $ | 427,348 | |||||||||||||||||||||||
| Stock-based compensation expense | 5,850 | 7,110 | 12,960 | 7,584 | 5,119 | 12,703 | |||||||||||||||||||||||||||||
| Amortization of acquired intangible assets | 1,730 | 8,572 | 10,302 | 1,318 | 4,081 | 5,399 | |||||||||||||||||||||||||||||
| Adjusted gross margin | $ | 210,475 | $ | 327,765 | $ | 538,240 | $ | 211,128 | $ | 234,322 | $ | 445,450 | |||||||||||||||||||||||
| Gross margin % | 43.0 | % | 71.4 | % | 56.7 | % | 49.9 | % | 73.8 | % | 60.1 | % | |||||||||||||||||||||||
| Adjusted gross margin % | 44.6 | % | 75.0 | % | 59.2 | % | 52.1 | % | 76.8 | % | 62.7 | % |
| Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||
| 2026 | 2025 | ||||||||||||||||||||||||||||||||||
| Connected Devices | Software and Services | Total | Connected Devices | Software and Services | Total | ||||||||||||||||||||||||||||||
| Gross margin | $ | 686,252 | $ | 852,459 | $ | 1,538,711 | $ | 555,794 | $ | 641,036 | $ | 1,196,830 | |||||||||||||||||||||||
| Stock-based compensation expense | 17,141 | 17,663 | 34,804 | 22,643 | 15,508 | 38,151 | |||||||||||||||||||||||||||||
| Amortization of acquired intangible assets | 5,189 | 24,380 | 29,569 | 3,988 | 11,560 | 15,548 | |||||||||||||||||||||||||||||
| Compensation taxes related to Employee XSP vesting | 426 | 633 | 1,059 | 634 | 854 | 1,488 | |||||||||||||||||||||||||||||
| Severance costs (1) | 121 | 20 | 141 | — | — | — | |||||||||||||||||||||||||||||
| Inventory step-up amortization | — | — | — | 607 | — | 607 | |||||||||||||||||||||||||||||
| Adjusted gross margin | $ | 709,129 | $ | 895,155 | $ | 1,604,284 | $ | 583,666 | $ | 668,958 | $ | 1,252,624 | |||||||||||||||||||||||
| Gross margin % | 48.0 | % | 71.7 | % | 58.7 | % | 49.5 | % | 74.5 | % | 60.4 | % | |||||||||||||||||||||||
| Adjusted gross margin % | 49.6 | % | 75.3 | % | 61.2 | % | 52.0 | % | 77.8 | % | 63.2 | % |
(1)For the nine months ended September 30, 2026, non-recurring severance costs recorded to cost of service and product sales consisted of stock-based compensation, cash payments and employee benefits.
Liquidity and Capital Resources
Summary
| September 30, 2026 | December 31, 2025 | Dollar Change | |||||||||||||||
| Cash and cash equivalents | $ | 1,458,817 | $ | 1,201,147 | $ | 257,670 | |||||||||||
| Available-for-sale investments | 181,587 | 505,417 | (323,830) | ||||||||||||||
| Total | $ | 1,640,404 | $ | 1,706,564 | $ | (66,160) |
Our most significant source of liquidity typically includes funds generated by operating activities and available cash and cash equivalents and short-term investments. As of September 30, 2026, we had $1.5 billion of cash and cash equivalents, an increase of $257.7 million from December 31, 2025. As of September 30, 2026, we had $181.6 million of available-for-sale investments, a decrease of $323.8 million from December 31, 2025, primarily due to sales and maturities of available-for-sale securities during the period. Refer to Note 3 in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional details.
In addition, our Credit Agreement is available for additional working capital needs or investment opportunities. As of September 30, 2026, we had letters of credit outstanding of approximately $9.1 million under the facility and available borrowing of $490.9 million. Refer to Note 8 in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional details.
As of September 30, 2026, we have an aggregate of $1.75 billion of Senior Notes and $1.15 billion of 2031 Notes outstanding. As of September 30, 2026, none of our subsidiaries guarantee the Senior Notes or 2031 Notes. Our non-guarantor subsidiaries accounted for approximately 19% of our total revenue for the nine months ended September 30, 2026, and approximately 17% and 6% of our total consolidated assets and liabilities (excluding the effect of intercompany transactions), respectively, as of September 30, 2026. Refer to Note 8 in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional details of the 2031 Notes.
On November 5, 2026, we entered into agreements to make incremental minority investments of up to $1.2 billion in Skydio. We expect the investments to be settled with up to approximately $720.0 million in cash and the remainder in shares of the Company’s common stock, with the final mix subject to the results of a tender offer and secondary purchases that are expected to close in the fourth quarter of 2026 and first quarter of 2027. We paid approximately $127.5 million in cash at the closing of the Company’s primary investment on November 5, 2026, and the remaining cash consideration will be funded utilizing our available cash on hand. Refer to Note 15 in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional details.
We believe we have access to additional financing. However, there is no assurance that such funding will be available on terms acceptable to us, or at all. We believe that our sources of funding will be sufficient to satisfy our currently anticipated cash requirements, including capital expenditures, working capital requirements, potential acquisitions or investments, income and payroll tax payments for net-settled stock awards, and other liquidity requirements through at least the next 12 months.
Going forward, we expect to continue to be an opportunistic issuer of debt securities and may issue new debt securities from time to time to fund our growth or refinance future debt maturities, among other things. In addition, from time to time, we may acquire our debt securities through open market purchases, redemptions, privately negotiated transactions, tender offers, exchange offers or otherwise, upon such terms and at such prices as we may from time to time determine, for cash or other consideration.
Cash Flows
The following table summarizes our cash flows from operating, investing and financing activities (in thousands):
| Nine Months Ended September 30, | Dollar Change | ||||||||||||||||
| 2026 | 2025 | ||||||||||||||||
| Operating activities | $ | 8,247 | $ | (5,896) | $ | 14,143 | |||||||||||
| Investing activities | (618,294) | (498,490) | (119,804) | ||||||||||||||
| Financing activities | 870,468 | 1,468,024 | (597,556) | ||||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | (1,786) | 5,741 | (7,527) | ||||||||||||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | $ | 258,635 | $ | 969,379 | $ | (710,744) |
Operating activities
Net cash provided by operating activities was $8.2 million for the nine months ended September 30, 2026 compared to net cash used in operating activities of $5.9 million for the nine months ended September 30, 2025.
The net operating cash inflow for the nine months ended September 30, 2026 includes net income of $255.7 million, an increase of $133.8 million when compared to the same period in the prior year. Primary drivers of the non-cash adjustments to net income during the nine months ended September 30, 2026 include $435.1 million of stock-based compensation expense for employee equity programs, $96.1 million of depreciation and amortization, and $36.1 million for deferred income taxes, partially offset by $257.6 million in fair value adjustments for net realized and unrealized gains and losses on our strategic investments and marketable securities. The realized and unrealized gains on our strategic investments were primarily driven by observable price changes for one of our investees. The deferred income taxes were primarily driven by investment-related gains and the amortization of previously capitalized R&D, partially offset by unvested stock-based compensation.
The change in operating assets and liabilities during the nine months ended September 30, 2026, when compared to the same period in the prior year, includes an increase in inventory purchases of $180.0 million, partially offset by $64.1 million of accounts payable, accrued and other liabilities. The increased inventory activity was primarily driven by advanced purchases of materials for TASER 10 CEDs and counter-drone equipment. Net of deferred revenue, our increase in receivables and contract assets of $19.2 million was driven by our increased sales, as well as the timing of invoicing and cash collections.
Investing activities
Net cash used in investing activities was $618.3 million for the nine months ended September 30, 2026 compared to $498.5 million for the nine months ended September 30, 2025. The net investing cash outflow is primarily driven by $552.0 million for business combination activity which is substantially all related to the Carbyne acquisition, $490.7 million for investment purchases which include $309.2 million of strategic investment purchases, and $82.8 million for purchases of property and equipment. The cash outflow was partially offset by $509.4 million of proceeds from calls, maturities and sales of available-for-sale and marketable securities investments. The increase in net cash outflow compared to the prior period is primarily driven by the acquisition of Carbyne, partially offset by decreased net purchases of available-for-sale and marketable securities and strategic investments.
Financing activities
Net cash provided by financing activities was $870.5 million for the nine months ended September 30, 2026 compared to $1.5 billion for the nine months ended September 30, 2025. The financing cash inflow in the current period was primarily driven by gross proceeds from the 2031 Notes issuance of $1.15 billion and $100.3 million of net cash proceeds from our ATM equity offering program. The proceeds were partially offset by $114.9 million of capped call purchases in relation to the 2031 Notes issuance, $167.2 million of income and payroll tax payments made on behalf of employees who net-settled stock awards during the period excluding $0.1 million which was not yet remitted as of September 30, 2026, $81.1 million of principal payments related to the redemption of our 2027 Notes, and $17.3 million of transaction expenses associated with the offering and revolver modifications. Net cash provided by financing activities in the prior period primarily reflects gross proceeds of $1.8 billion from the Senior Notes issuance, partially offset by principal payments of $407.5 million related to the induced conversion of our 2027 Notes during the nine months ended September 30, 2025. The decrease in net cash inflow compared to the prior period is primarily driven by lower proceeds from debt and equity issuances and capped call premiums paid in the current period, partially offset by fewer principal payments.
Critical Accounting Estimates
Our management’s discussion and analysis of our financial condition and results of operation is based on our consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances, and we evaluate our estimates and assumptions on an ongoing basis. While we do not believe that a change in these estimates is reasonably likely, there can be no assurance that our actual results will not differ from these estimates.
Our critical accounting estimates are discussed in our 2025 Annual Report on Form 10-K for the fiscal year ended December 31, 2025. There have been no significant changes to these critical accounting estimates for the nine months ended September 30, 2026.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Interest Rate Risk
We historically invested in various financial instruments which have consisted principally of money market accounts, certificates of deposit, and corporate and municipal bonds with a typical long-term debt rating of “A” or better by any nationally recognized statistical rating organization, denominated in U.S. dollars. All of our cash equivalents and investments are treated as “available-for-sale”. Based on investment positions as of September 30, 2026, a hypothetical 100 basis point increase in interest rates across all maturities would result in a $0.4 million decline in the fair market value of the portfolio. Such losses would only be realized if we sold the investments prior to maturity.
Additionally, we have access to a $500.0 million line of credit borrowing facility which bears interest at SOFR plus 1.25% to 1.75% per year determined in accordance with a pricing grid based on our maximum net leverage ratio and minimum interest coverage ratio. Under the terms of the line of credit, available borrowings are reduced by outstanding letters of credit, which totaled $9.1 million at September 30, 2026. At September 30, 2026, there was no amount outstanding under the line of credit, and the available borrowing under the line of credit was $490.9 million. We have not borrowed any funds under the line of credit since its inception; however, should we need to do so in the future, such borrowings could be subject to adverse or favorable changes in the underlying interest rate.
There have been no other material changes in our primary risk exposures or management of risks since the prior year.
Exchange Rate Risk
Our results of operations and cash flows are subject to fluctuations due to changes in foreign currency exchange rates, in each case compared to the U.S. dollar, related to transactions by our foreign subsidiaries. The majority of our sales to international customers are transacted in foreign currencies and therefore are subject to exchange rate fluctuations on these transactions. The cost of our products to our customers increases when the U.S. dollar strengthens against their local currency, and we may have more sales and expenses denominated in foreign currencies in future years which could increase our foreign exchange rate risk. Additionally, intercompany sales to our non-U.S. dollar functional currency international subsidiaries are transacted in U.S. dollars which could increase our foreign exchange rate risk caused by foreign currency transaction gains and losses.
To date, we have not engaged in any currency hedging activities. However, we may enter into foreign currency forward and option contracts with financial institutions to protect against foreign exchange risks associated with certain existing assets and liabilities, certain firmly committed transactions, forecasted future cash flows and net investments in foreign subsidiaries. However, we may choose not to hedge certain foreign exchange exposures for a variety of reasons, including, but not limited to, the prohibitive economic cost of hedging particular exposures. As such, fluctuations in currency exchange rates could harm our business in the future.
There have been no other material changes in our primary risk exposures or management of risks since the prior year.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our Chief Executive Officer and Chief Financial Officer are responsible for the evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q. Our disclosure controls and procedures are designed to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2026.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
The discussion in Note 11 to our consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated by reference herein.
Item 1A. Risk Factors
There have been no material changes to the risk factors outlined in our Annual Report on Form 10-K for the year ended December 31, 2025, with the exception of the following risks related to our indebtedness. Refer to Note 8 to our consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional details.
Our 2027 Note Hedge, 2027 Warrant, and 2031 Capped Call transactions may impact the value of our common stock.
In connection with the pricing of the 2027 Notes, we entered into 2027 Note Hedge transactions and 2027 Warrant transactions with certain investment banks (together with the 2031 Option Counterparties, the “Option Counterparties”). We entered into agreements with the 2027 Option Counterparties in March 2025 to leave the 2027 Note Hedge transactions outstanding until the original maturity of the 2027 Notes in respect of the 2027 Notes we exchanged in March 2025. Further, we unwound a portion of the 2027 Note Hedge and 2027 Warrant transactions in conjunction with our redemption of all of our outstanding 2027 Notes. As of the date of filing this Quarterly Report on Form 10-Q, a portion of the 2027 Note Hedge and 2027 Warrant transactions were still outstanding, notwithstanding the extinguishment of our 2027 Notes. As a result, the 2027 Warrant transactions could have a dilutive effect on our common stock to the extent that the market price per share of our common stock exceeds the strike price of the 2027 Warrants.
In September 2026, in connection with the pricing of the 2031 Notes, we entered into the 2031 Capped Calls with the 2031 Option Counterparties, which may reduce potential dilution to our common stock or offset any potential cash payments we are required to make in excess of the principal amount of converted 2031 Notes, as the case may be, with such reduction or offset subject to a cap. The 2031 Capped Calls do not offset any potential dilutive effect for purposes of calculating diluted income per common share. Additionally, the Option Counterparties or their affiliates may adjust their hedge positions by entering into or unwinding various derivatives linked to our common stock, or by buying or selling our common stock or other securities in secondary market transactions. Such actions could cause fluctuations in the market price of our common stock, potentially causing it to rise or fall. If any of the 2027 Note Hedge, 2027 Warrant or 2031 Capped Call transactions do not perform as anticipated, the 2027 Option Counterparties or 2031 Option Counterparties, as the case may be, may unwind their positions, which could adversely affect our stock price.
The effect of these transactions and related activities on the market price of our common stock will depend in part on market conditions and other factors beyond our control, and their impact cannot be ascertained at this time. Any of these activities could adversely affect the value of our common stock.
We are exposed to counterparty risk with respect to the 2027 Note Hedge and 2031 Capped Call transactions.
The Option Counterparties are financial institutions, and we face the risk that any or all of them might default on their obligations under the 2027 Note Hedge transactions or the 2031 Capped Call transactions. Our exposure to this credit risk is unsecured, as the Option Counterparties have not secured their obligations by any collateral.
If an Option Counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings with a claim equal to our exposure under the 2027 Note Hedge transactions or the 2031 Capped Call transactions, as applicable, at that time. Our exposure will depend on many factors, including an increase in the market price and volatility of our common stock. An Option Counterparty default could also have tax consequences, could reduce the anticipated benefits of the 2027 Note Hedge transactions or the 2031 Capped Call transactions, as applicable, and could increase dilution relative to our current expectations. We cannot provide assurances as to the financial stability or solvency of the Option Counterparties, and any default could materially and adversely affect our financial results.
Our indebtedness contains restrictive covenants that could limit our operational flexibility and adversely affect the value of our common stock.
Our revolving credit facility, as amended in September 2026, and the indentures governing our 2030 Notes, 2031 Notes and 2033 Notes (collectively, the “Notes”) impose certain restrictions, as applicable, on our ability to, among other matters, incur additional debt and liens, make distributions to our shareholders in certain circumstances, dispose of assets and enter into mergers, consolidations, and transfers of all or substantially all of our assets. In addition, the revolving credit facility requires us to maintain specified financial ratios and satisfy other financial condition tests. Further, following certain change of control events, we would be required to offer to repurchase the Notes, and such events would also constitute an event of default under our revolving credit facility. The indenture governing the 2031 Notes contains customary provisions relating to consolidation, merger, and sale of assets and certain protections in connection with a “Fundamental Change” and certain make-whole events, as described therein.
These limitations may restrict our ability to operate our business, pursue strategic transactions, or otherwise respond to changing business or economic conditions. Consequently, compliance with these covenants could adversely affect our business and the value of our common stock.
The conditional conversion and settlement features of the 2031 Notes may adversely affect our liquidity, financial condition, and existing stockholders. Prior to June 15, 2031, holders of the 2031 Notes may convert their notes only during specified periods under specified conditions. If the conditional conversion feature is triggered, holders may convert their 2031 Notes at any time during specified periods. On or after June 15, 2031, holders of the 2031 Notes may convert their 2031 Notes at any time. If one or more holders elect to convert their 2031 Notes, unless we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than paying cash in lieu of delivering any fractional share), we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity.
Even if no holders convert their 2031 Notes, under applicable accounting rules we may be required, in certain circumstances, to reclassify some or all of the outstanding principal amount of the 2031 Notes from a long-term to a current liability, which would reduce our reported working capital. If we settle our conversion obligations or any repurchase obligations arising upon a “Fundamental Change” under the 2031 Notes, in whole or in part, through the issuance of shares of our common stock, that issuance could dilute the ownership interests of our existing stockholders and could depress the market price of our common stock.
Conversion of the 2031 Notes, or any issuance or delivery of our common stock in connection with the Holder Repurchase Option under the 2031 Notes, may dilute the ownership interest of our stockholders or may otherwise depress the price of our common stock.
The conversion of some or all of the 2031 Notes, or any issuance or delivery of our common stock in connection with the Holder Repurchase Option under the 2031 Notes, may dilute the ownership interests of our stockholders. Upon conversion of the 2031 Notes, we have the option to pay or deliver, as the case may be, cash, shares of our common stock, or a combination of cash and shares of our common stock, at our election. In addition, we may elect to satisfy some or all of our obligation in respect of the principal amount of the repurchase price for holders exercising any Holder Repurchase Option by issuing or delivering shares of our common stock in certain circumstances. If we elect to settle our conversion obligation in shares of our common stock or a combination of cash and shares of our common stock, or to deliver any shares of our common stock in connection with the Holder Repurchase Option, any sales in the public market of our common stock so issuable could adversely affect prevailing market prices of our common stock. In addition, the existence of the 2031 Notes may encourage short selling by market participants because the shares of our common stock issuable or deliverable upon conversion of the 2031 Notes or in connection with the Holder Repurchase Option, as the case may be, could be used to satisfy short positions, or anticipated conversion of the 2031 Notes into shares of our common stock, or anticipated issuance or delivery of shares of our common stock in connection with the Holder Repurchase Option, could depress the price of our common stock.
Fulfilling our debt obligations requires significant cash resources, which may exceed our available cash flow.
Our ability to meet our debt obligations, including making scheduled principal and interest payments, refinancing obligations, and satisfying conversion or repurchase obligations under our 2031 Notes, depends on our future performance and external factors beyond our control. In particular, we may need cash to satisfy obligations arising from the maturity or refinancing of our outstanding notes, conversions of the 2031 Notes to the extent we elect or are required to settle any portion of our conversion obligations in cash, repurchases of the 2031 Notes following a fundamental change, or repurchases of the 2031 Notes for cash in connection with any exercises of the Holder Repurchase Option under the 2031 Notes. If our business fails to generate sufficient cash flow from operations to meet these obligations and fund capital expenditures, we may be required to adopt alternatives (for example, asset sales, debt restructuring or equity financing) that may be on unfavorable or dilutive terms. Further, our ability to refinance our indebtedness will depend on market conditions and our financial standing at such time, which may be unfavorable. If we are unable to identify or pursue acceptable alternatives on commercially reasonable terms, we could be unable to meet our debt obligations, which could result in a default.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
None.
Item 6. Exhibits
+Management contract or compensatory plan or arrangement
*Filed herewith
**Furnished herewith
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| AXON ENTERPRISE, INC. | |||||||||||
| Date: | November 5, 2026 | ||||||||||
| By: | /s/ PATRICK SMITH | ||||||||||
| Chief Executive Officer | |||||||||||
| (Principal Executive Officer) | |||||||||||
| Date: | November 5, 2026 | By: | /s/ BRITTANY BAGLEY | ||||||||
| Chief Operating Officer and Chief Financial Officer | |||||||||||
| (Principal Financial Officer) |